Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRN | P28799 | 1/20 | 0.50 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.50 |
| ▸ | CPB2 | Q96IY4 | 10/20 | 0.45 |
| ▸ | LTA4H | P09960 | 2/20 | 0.43 |
| ▸ | CTSK | P43235 | 3/20 | 0.43 |
| ▸ | CTSS | P25774 | 2/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7566961 | 1.00 | GRN (0.50) | GRNSORT1CPB2LTA4HCTSK | |
| SCHEMBL7571759 | 1.00 | GRN (0.50) | GRNSORT1CPB2LTA4HCTSK | |
| SCHEMBL19750968 | 1.00 | GRN (0.50) | GRNSORT1CPB2LTA4HCTSK | |
| SCHEMBL19050196 | 1.00 | GRN (0.50) | GRNSORT1CPB2LTA4HCTSK | |
| SCHEMBL24965929 | 0.98 | GRN (0.48) | GRNSORT1CPB2LTA4HCTSK | |
| SCHEMBL5275514 | 0.98 | GRN (0.48) | GRNSORT1CPB2LTA4HCTSK | |
| SCHEMBL15764276 | 0.94 | GRN (0.44) | GRNSORT1CPB2LTA4HCTSK | |
| SCHEMBL22122370 | 0.94 | GRN (0.44) | GRNSORT1CPB2LTA4HCTSK | |
| SCHEMBL25357322 | 0.94 | GRN (0.44) | GRNSORT1CPB2LTA4HCTSK | |
| SCHEMBL19066729 | 0.90 | GRN (0.46) | GRNSORT1CPB2CTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1853626-A2 | AMYLOID-BINDING PEPTIDES, ANALOGUES AND USES THEREOF | Senexis Limited (GB) | 2007-11-14 | — | — | EP | claimed |
| WO-2006087550-A2 | AMYLOID-BINDING PEPTIDES, ANALOGUES AND USES THEREOF | SENEXIS LIMITED (GB) | 2006-08-24 | — | — | WO | claimed |
| WO-2022129630-A1 | G PROTEIN PEPTIDOMIMETICS | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2022-06-23 | — | — | WO | disclosed |
| US-20120071329-A1 | METHODS FOR IDENTIFYING COMPOUNDS OF INTEREST USING ENCODED LIBRARIES | GLAXOSMITHKLINE LLC (US) | 2012-03-22 | — | — | US | disclosed |
| US-20110251089-A1 | METHODS FOR SYNTHESIS OF ENCODED LIBRARIES | GLAXOSMITHKLINE (US) | 2011-10-13 | — | — | US | disclosed |
| US-7989395-B2 | Methods for identifying compounds of interest using encoded libraries | GLAXOSMITHKLINE LLC (US) | 2011-08-02 | — | — | US | disclosed |
| EP-1853626-A2 | AMYLOID-BINDING PEPTIDES, ANALOGUES AND USES THEREOF | Senexis Limited (GB) | 2007-11-14 | — | — | EP | disclosed |
| WO-2006087550-A2 | AMYLOID-BINDING PEPTIDES, ANALOGUES AND USES THEREOF | SENEXIS LIMITED (GB) | 2006-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251089-A1 | METHODS FOR SYNTHESIS OF ENCODED LIBRARIES | RNGTT, DTYMK, DUT | GRN 4358/4885SORT1 2143/4885CPB2 1521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.